In phase II, randomized, open-label study, the addition of ramucirumab to capecitabine in previously treated patients with locally advanced and metastatic breast cancer failed to improve PFS and OS compared to capecitabine therapy alone (Vahdat et al., 2017)
Yoon SY, dela Pena I, Kim SM, Woo TS, Shin CY, Son KH, et al
Prescription GLP-1 medications (Tirzepatide) Patients struggling with weight loss despite diet and exercise Mimics natural gut hormones to regulate appetite and blood sugar Gradual, sustainable weight loss with lifestyle support Medical weight loss refers to a physician-supervised program that uses prescription medications, lifestyle guidance, and ongoing monitoring to help individuals lose weight and improve their health
All diese Effekte, die ebenfalls durch GLP-1-Rezeptoragonisten erreicht werden, fhren zu einer Senkung des Blutzuckerspiegels unter anderem durch Interaktion mit dem G s -Protein gekoppelten GLP-1-Rezeptor
Interestingly, diet intervention seems to affect plasma L-Cn levels
